Insider Transactions Reported by 21 Insiders of BridgeBio Pharma, Inc.

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
VIKING GLOBAL INVESTORS LP 10%+ Owner $816,436,500 -$154,000,000 -16% 27 Jun 2025
KKR Genetic Disorder L.P. 10%+ Owner $453,525,208 -$205,200,000 -31% 12 May 2025
Neil Kumar Chief Executive Officer, Director $373,218,808 -$59,762,646 -14% 12 Mar 2026
Frank Mccormick Director $51,404,193 -$21,669,537 -30% 29 Oct 2025
Charles J. Homcy Director $44,000,352 -$13,912,443 -24% 08 Aug 2025
Thomas Trimarchi President and CFO $25,371,777 -$5,103,355 -17% 16 Feb 2026
Maricel Apuli Chief Accounting Officer $8,048,370 -$403,367 -4.8% 26 Feb 2026
Brian C. Stephenson CFO and Treasurer $6,443,801 25 Feb 2025
Ali J. Satvat Director $5,451,210 20 Jun 2025
Andrew Lo Director $4,285,707 -$10,169,562 -70% 17 Nov 2025
James C. Momtazee Director $3,122,427 20 Jun 2025
Richard H. Scheller Director $2,421,359 16 Feb 2023
Andrea Ellis Director $1,205,833 -$6,423,985 -84% 04 Mar 2026
Randal W. Scott Director $1,199,547 -$1,421,022 -54% 17 Feb 2026
Ronald J. Daniels Director $1,082,695 -$3,888,999 -78% 06 Nov 2025
Douglas A. Dachille Director $873,182 20 Jun 2025
Fred Hassan Director $850,194 20 Jun 2025
Hannah Valantine Director $564,563 -$4,404,828 -89% 10 Mar 2026
Jennifer E. Cook Director $451,254 20 Jun 2025
Eric Aguiar Director $216,382 20 Jun 2025
Brent L. Saunders Director 22 Jun 2022

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Neil Kumar BBIO Common Stock Sale -0.45% $1,375,913 $68.80 -20,000 4,438,447 13 Mar 2026 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -3.05% $1,375,890 $68.79 -20,000 635,686 13 Mar 2026 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -0.45% $1,374,660 $68.73 -20,000 4,458,447 12 Mar 2026 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.96% $1,374,605 $68.73 -20,000 655,686 12 Mar 2026 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Hannah Valantine BBIO Common Stock Sale -53.7% $624,312 $72.00 -8,671 7,465 10 Mar 2026 Direct
Hannah Valantine BBIO Common Stock Options Exercise 116.2% 8,671 16,136 10 Mar 2026 Direct
Hannah Valantine BBIO Stock Option (Right to Buy) Options Exercise -33.3% -8,671 17,343 10 Mar 2026 Direct
Andrea Ellis BBIO Common Stock Sale -77.7% $4,211,302 $64.87 -64,921 18,589 04 Mar 2026 Direct
Andrea Ellis BBIO Common Stock Options Exercise 349.2% 64,921 83,510 04 Mar 2026 Direct
Andrea Ellis BBIO Stock Option (right to buy) Options Exercise -100% -64,921 0 04 Mar 2026 Direct
Hannah Valantine BBIO Common Stock Sale -77.3% $1,717,781 $67.41 -25,484 7,465 27 Feb 2026 Direct
Hannah Valantine BBIO Common Stock Options Exercise 341.4% 25,484 32,949 27 Feb 2026 Direct
Hannah Valantine BBIO Stock Option (Right to Buy) Options Exercise -100% -25,484 0 27 Feb 2026 Direct
Maricel Apuli BBIO Common Stock Sale -1.61% $132,000 $66.00 -2,000 121,945 26 Feb 2026 Direct
Neil Kumar BBIO Common Stock Sale -10.7% $2,002,717 $71.39 -28,053 234,451 19 Feb 2026 Direct
Maricel Apuli BBIO Common Stock Sale -0.41% $37,898 $74.31 -510 123,945 17 Feb 2026 Direct
Thomas Trimarchi BBIO Common Stock Sale -3.88% $1,016,147 $74.72 -13,600 336,585 17 Feb 2026 Direct
Randal W. Scott BBIO Common Stock Sale -46.3% $754,557 $75.46 -10,000 11,589 17 Feb 2026 Direct
Randal W. Scott BBIO Common Stock Options Exercise 86.3% 10,000 21,589 17 Feb 2026 Direct
Randal W. Scott BBIO Stock Option (Right to Buy) Options Exercise -24.1% -10,000 31,501 17 Feb 2026 Direct
Neil Kumar BBIO Common Stock Tax liability -10.6% -30,970 262,504 16 Feb 2026 Direct
Neil Kumar BBIO Common Stock Options Exercise 28.3% 64,698 293,474 16 Feb 2026 Direct
Neil Kumar BBIO Restricted Stock Units Options Exercise -32.5% -64,698 134,176 16 Feb 2026 Direct
Maricel Apuli BBIO Common Stock Tax liability -3.38% -4,349 124,455 16 Feb 2026 Direct
Thomas Trimarchi BBIO Common Stock Tax liability -5.1% -18,819 350,185 16 Feb 2026 Direct
Neil Kumar BBIO Common Stock Sale -0.44% $1,435,544 $71.78 -20,000 4,478,447 11 Feb 2026 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.87% $1,435,543 $71.78 -20,000 675,686 11 Feb 2026 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -0.44% $1,438,757 $71.94 -20,000 4,498,447 10 Feb 2026 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.79% $1,438,822 $71.94 -20,000 695,686 10 Feb 2026 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -0.44% $1,542,115 $77.11 -20,000 4,518,447 09 Jan 2026 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.72% $1,542,198 $77.11 -20,000 715,686 09 Jan 2026 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -0.44% $1,479,433 $73.97 -20,000 4,538,447 08 Jan 2026 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.65% $1,479,422 $73.97 -20,000 735,686 08 Jan 2026 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -11.6% $2,239,902 $74.64 -30,011 228,776 15 Dec 2025 Direct
Neil Kumar BBIO Common Stock Tax liability -10.7% -30,964 258,787 12 Dec 2025 Direct
Neil Kumar BBIO Common Stock Options Exercise 26.6% 60,975 289,751 12 Dec 2025 Direct
Neil Kumar BBIO Restricted Stock Units Options Exercise -50% -60,975 60,976 12 Dec 2025 Direct
Thomas Trimarchi BBIO Common Stock Tax liability -3.61% -13,826 369,004 12 Dec 2025 Direct
Maricel Apuli BBIO Common Stock Tax liability -1.54% -2,003 128,294 12 Dec 2025 Direct
Maricel Apuli BBIO Common Stock Sale -1.51% $148,520 $74.26 -2,000 130,297 08 Dec 2025 Direct
Neil Kumar BBIO Common Stock Sale -0.44% $1,466,287 $73.31 -20,000 4,558,447 05 Dec 2025 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.58% $1,466,276 $73.31 -20,000 755,686 05 Dec 2025 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -0.43% $1,487,954 $74.40 -20,000 4,578,447 04 Dec 2025 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -2.51% $1,487,958 $74.40 -20,000 775,686 04 Dec 2025 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Neil Kumar BBIO Common Stock Sale -10.3% $1,722,224 $65.84 -26,156 228,776 20 Nov 2025 Direct
Andrew Lo BBIO Common Stock Sale -52.1% $3,613,069 $65.69 -55,000 50,583 18 Nov 2025 By Andrew W. Lo and Nancy N. Lo JTWROS
Andrew Lo BBIO Common Stock Sale -74.2% $2,706,593 $66.67 -40,599 14,089 17 Nov 2025 Direct
Randal W. Scott BBIO Common Stock Sale -46.3% $666,465 $66.65 -10,000 11,589 17 Nov 2025 Direct
Randal W. Scott BBIO Common Stock Options Exercise 86.3% 10,000 21,589 17 Nov 2025 Direct
Randal W. Scott BBIO Stock Option (Right to Buy) Options Exercise -19.4% -10,000 41,501 17 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.